17:04 EDT Caribou Biosciences (CRBU) files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBU:
- Caribou Biosciences price target lowered to $9 from $11 at BofA
- Strategic Refocus and Upcoming Catalysts Support Buy Rating for Caribou Biosciences
- Caribou Biosciences price target lowered to $3 from $9 at H.C. Wainwright
- Strategic Restructuring and Focus on Oncology Drive Buy Rating for Caribou Biosciences
- Caribou reduces workforce by 32%, discontinues GALLOP and AMpLify trials